Bio-Rad has entered a binding offer to purchase all equity interests in French biotech Stilla Technologies. According to ...

By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.

Some public health data targeted by Trump’s executive orders has been restored, but what’s changed and how will that affect health policy?

They also identified “L protein features that are required for both transcription and RNA replication and mutations that have a greater impact on RNA replication than on transcription.” ...

Expert Rev Mol Diagn. 2009;9(8):777-785. © 2009 Expert Reviews Ltd. Cite this: GUCY2C Reverse Transcriptase PCR to Stage pN0 Colorectal Cancer Patients - Medscape ...

Recently, a prospective, multicenter, blinded clinical trial demonstrated for the first time that the prognostic utility of GUCY2C quantitative reverse transcriptase (qRT)-PCR to detect occult ...